MedicalResearch.com Interview with:
Roman Hovorka PhD FMedSci
Director of Research
University of Cambridge Metabolic Research Laboratories
Wellcome Trust-MRC Institute of Metabolic Science
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Inpatient diabetes is generally not managed well when patients are admitted for a range of health issues on the general ward.
MedicalResearch.com: What should readers take away from your report?
Response: Closed-loop systems (the artificial pancreas) can improve substantially glucose control for inpatient needing insulin on the general ward without increasing the risk of hypoglycaemia.
MedicalResearch.com: What recommendations do you have for future research as a result of this work?
Response: Large studies are needed to assess the wider benefits of closed-loop for managing inpatients on the general ward.
MedicalResearch.com: Is there anything else you would like to add?
Response: The results surpassed expectations and suggest an important role of the artificial pancreas not only in type 1 diabetes but also for inpatient diabetes.
Lia Bally, Ph.D., Hood Thabit, Ph.D., Sara Hartnell, B.Sc., Eveline Andereggen, R.N., Yue Ruan, Ph.D., Malgorzata E. Wilinska, Ph.D., Mark L. Evans, M.D., Maria M. Wertli, Ph.D., Anthony P. Coll, M.D., Christoph Stettler, M.D., and Roman Hovorka, Ph.D.
NEJM June 25, 2018
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.